Summaries & Associations of Study Results
TR-207 Cytembena
Target Organs and Levels of Evidence
NTP Technical Report Number 207
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| CYTEMBENA 21739-91-3 |
06/27/80 | CYTOSTATIC AGENT (FORMERLY) | Intraperitoneal Injection R: 0,7,14, M: 0,12,24 MG/KG/50 PER GROUP | Southern Research Institute |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: POSITIVE | MESOTHELIUM (ABDOMINAL CAVITY/TUNICA VAGINALIS): MESOTHELIOMA 0/50 37/50 36/50 | |||
| FR: POSITIVE | MAMMARY GLAND: FIBROADENOMA 13/49 22/50 36/50 | |||
| MM: NEGATIVE | ||||
| FM: NEGATIVE | ||||
Web page last updated on February 10, 2006
